CALIXAR to open First Commercial Branch in Japan

March 7, 2013

As part of its international development strategy, CALIXAR opened his first commercial branch in Tokyo, Japan to facilitate access to its technology on this market (See contact tab).

DATES : 07/03/2013

Read the article

Conformational antibody development

Vaccine development

Ligand high-throughput screening

Structure-based drug discovery

Immunoassays

Deorphanization projects

Identification of relevant targets

Expression of full-length membrane proteins

Functional isolation and stabilization of targets

Conformational antibody development

Vaccine development

High-throughput ligand screening

Structure-based drug discovery

Immunoassays

Deorphanization projects

Identification of relevant targets

Expression of full-length membrane proteins

Functional isolation and stabilization of targets

Secure and boost
your discovery programs.

Starting from native material or recombinant systems, we succeed with all types of membrane proteins: GPCRs, Ion Channels, Transporters, Receptors and Viral Proteins.

Our partners